6
MARKET Diary Institutional Services
Value % Change
SGX NIFTY 8,009.00 -0.36%
19199.58 -1.05%
HANG SENG 21,681.40 -0.34%
Sensex 26,210.68 -0.01%
Nifty 8,034.85 0.02%
DOW 19,833.68 -0.56%
NASDAQ 5,438.56 -0.90%
CAC 4,848.01 -0.01%
Event Today DAX 11,474.99 0.02%
FTSE 7,106.08 0.53%
EW ALL SHARE 14,365.85 0.32%
JBMA : General
Value % Change
27300.00 0.48%
39420.00 0.77%
53.76 -0.55%
261.80 2.23%
68.24 0.25%
71.16 0.19%
83.47 0.09%
Investor Buy(Cr.) Sale(Cr.) Net(Cr.)
28-Dec-16 2295 2822 (527)
Dec-16 67831 77708 (9877)
2016 1048097 1055124 (7028)
Investor Buy(Cr.) Sale(Cr.) Net(Cr.)
28-Dec-16 2207 1382 825
Dec-16 36520 29067 7454
2016 491544 455774 35770
Microsec Capital Limited
Morning Traded Market
Nifty Intraday Chart Market
Institutional Turnover
Yesterday Closing Market
POUND/RS.
Market Outlook
CRUDEOIL
Board Meetings
Quote of the Day : "While enthusiasm may be necessary for great accomplishments elsewhere, on Wall
Street it almost invariably leads to disaster." Benjamin Graham
FII
29-Dec-16
DII
Commodity Price ( Yesterday Closing )
GOLD
NATURALGAS
DOLLAR/RS.
EURO/RS.
Commodity/Currencies
SILVER
Market
NIKKIE
% Change in 1 day
% Change in 1 day
Indian equities gave a range bound and
choppy movement through the day on
Wednesday and after opening on subdued
note, Nifty traded in the band of 8035-8099.
At the end of the index closed at 8034.85
ahead of December Future & option( F&O)
expiry today. It had a net loss of 0.02% over
the previous day’s close. The midcap and small
cap indices also moved in line with the
benchmark index and closed the day after
gaining 0.33% -0.97%
On the sectoral front, some selling pressure
was witnessed in Energy, Banking, Auto and
Metal stocks while Realty and Information
Technology , FMCG , Pharma indices closed in
green. The breadth of the market was poor .
Market experts see a low start to 2017 with
Union Budget being the next big trigger after
third quarter earnings.
The foreign investors were the net sellers in
the cash segment. They sold 527 Crores worth
of equities on Wednesday.
Sharp upswing yesterday has brought Nifty
back inside its trading range of 8000- 8200.
Frequent sharp changes in open interest of
various calls and puts around 8000 suggest
indecisiveness among market participants.
Also open interest built up for January series is
not significant enough to suggest any decisive
move for the market just now.
KEY LEVELS
Support 1 : 7941
Resistance 1: 8111 Resistance 2: 8229
Microsec Capital Limited
IEA Snapshot
"BUY"
"NEUTRAL"
Top News
BEL
The company is having robust order intake during H1FY17 which gives decent revenue growth visibility going forward and this is expected
to remain in the range of Rs 10000cr-15000cr over the next two-three years. Currently, the defence sector is in the limelight due to the
government’s strong focus on making defence procurements central to the “Make in India” campaign. The company has ~35% market
share in India’s defence electronics segment and is likely to be one of the biggest beneficiaries of the offset clause. Based on above
mentioned reasons we see strong medium-term earnings visibility for the company, hence we recommend “BUY” at a target price of Rs
1607 (Potential upside 22%).
The company is cautious in taking new orders in the EMPS segment and its focus is primarily on Govt. projects i.e. smart cities, rural
electrification and water treatment wherein execution cycle is steady and payments are secured. Management expects profitability to
improve after closing most of its low-margin and loss-making legacy projects by end-FY17. Going forward we expect near-term earnings to
be under pressure due to lower sales and margin in the UCP segment and continued subdued performance in EMPS segment. Right now
we are not seeing any major uptick in demand so we revised our estimates with flat revenue growth from 5% to 0.7% in FY17E and
presently we are “NEUTRAL” on this stock at a revised target of Rs 330 (from Rs 345).
28th Dec 2016
29th Dec 2016
VOLTAS
U.K. Index of Services rose to 1.0%, from 0.8% in the preceding month.
Analysts had expected U.K. Index of Services to rise 0.9% last month.
*For details, refer to our daily report- India Equity Analytics
• JMC Projects (India) Ltd has bagged new construction projects
worth over Rs 1,457 crore. The company has bagged Rs 454 crore
shipyard modernisation project in Goa, Rs 446 crore flyover project in
Maharashtra, Rs 282 crore commercial project in Hyderabad, Rs 224
crore residential project in Bangalore. The company also bagged
educational building project worth Rs 51 crore in Amravati, Andhra
Pradesh.
• Reliance Industries announced the commissioning of the
first phase of its Paraxylene (PX) plant at Jamnagar. The plant
with capacity of 2.2 million tons per annum is built with state-of-
the-art crystallisation technology from BP which is highly energy
efficient and environment friendly. With the commissioning of
this plant, RIL's PX capacity will more than double from 2.0
million tons to 4.2 million tons per annum . On commissioning
of entire PX capacity, Reliance will be the world's second largest
PX producer with 9 per cent of global PX capacity and 11 per
cent share of global production.
• Zydus Cadila has acquired six brands from global pharma
major MSD and its subsidiaries for an undisclosed amount. The
company's wholly-owned subsidiary Zydus Healthcare Ltd has
acquired six brands, which cover various therapeutic areas
including wound management, from MSD and its subsidiaries .
MSD India is an affiliate of Merck & Co Inc that operates in more
than 140 countries around the world. The acquired brands Deca-
Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten
range had clocked sales of Rs 840 million in 2015.
• Tata Steel said it is in discussion with foreign companies for
investments in heavy industries over the next five years at the
Special Economic Zone project at Gopalpur in Odisha. Tata Steel
India's Jamshedpur and Kalinganagar facilities together clocked
1 MT of monthly sales in September 2016. Despite challenging
times, we continue to remain a competitive and growth-
oriented Integrated Steel Company in the country
• Japan industrial production rose to a seasonally adjusted 1.5%, from
0.0% in the preceding month. Analysts had expected industrial
production to rise 1.6% last month.
• JK Tyre & Industries said its board has given approval to raise up to Rs
1,000 crore by issuing securities. The board approved raising of funds by
issue of securities, convertible/non-convertible with or without
warrant...by way of public and or private offerings for an amount of up
to Rs 1,000 crore in one of more tranches
• U.S. Pending home sales fell to a seasonally adjusted -2.5%, from
0.1% in the preceding month. Analysts had expected Pending home
sales to rise to 0.5% last month.
• U.K. BAA mortgage approvals fell to a seasonally adjusted 40.7K,
from 40.8K in the preceding month whose figure was revised down
from 40.9K. Analysts had expected BAA mortgage approvals to rise to
41.6K last month.
Microsec Capital Limited
Scrip Reco Initiation Price Target 2 Stop Loss
BPCL Buy 612 650 598
TRADING IDEAS
RationalTarget 1
635Stochastic is showing strength with good
volume. ATM & OTM CE writters are also
unwinding their postion.
F&O OPEN INTEREST ( Number of Contracts )
Individual
Nifty Movers
Foreign Institutions
NSE Sectoral Indices Performance
MARKET MOVERS (1 MONTH CHANGE)
Domestic Institutions Proprietary
Microsec Capital Limited
CountryMonday
26th Dec 16
Tuesday
27th Dec 16
Wednesday
28th Dec 16
Thursday
29th Dec 16
Friday
30th Dec 16
US
CB Consumer
Confidence , Richmond
Manufacturing Index ,
S&P/CS Composite-20
HPI y/y .
Pending Home Sales m/m.
Unemployment Claims , Crude
Oil Inventories , Natural Gas
Storage , Goods Trade Balance.
Chicago PMI.
UK/EURO ZONE
Current Account , Final
GDP q/q , Index of
Services 3m/3m ,
Revised Business
Investment q/q .
German Import Prices m/m
,GfK German Consumer
Climate.
Spanish Flash CPI y/y , M3
Money Supply y/y , Private
Loans y/y .
Housing Equity
Withdrawal q/q
INDIA
Economic Calendar
Microsec Capital Limited
DISCLAIMER
This document has been prepared by Microsec Capital Limited (hereinafter referred to as MCL) to provide information about the
Company (ies)/ sector(s), if any, covered in the report and may be distributed by it and/or its associates.
This report does not construe to be any investment, legal or taxation advice. This research report does not constitute an offer, invitation
or inducement to invest in securities or other investments and MCL is not soliciting any action based upon it. This report should not be
reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into
account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or
recommendation in this report, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek
professional advice. Neither MCL, its subsidiaries/ Associates, nor its directors, employees, agents, representatives shall be liable for any
damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in
connection with the use of the information/research reports/ opinions expressed herein.
While we would endeavour to update the information herein on reasonable basis, MCL and/or its associates are under no obligation to
update the information. Also there may be regulatory, compliance, or other reasons that may prevent MCL and/or its associates from
doing so. MCL/it’s associates or employees shall not in any way be responsible and liable for any loss or damage that may arise to any
person from any inadvertent error in the information contained in this report. MCL/it’s associates or employees do not provide, at any
time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied
warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their
own investigations.
MCL and its associates, their directors and employees and their relatives may; (a) from time to time, have a long or short position in, act
as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other
transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of
the company(ies) discussed herein or may have any other potential conflict of interests with respect to any recommendation and other
related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the
analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MCL even
though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report.
MCL and/or its affiliates and/or employees may have interests/positions, financial or otherwise of over 1% at the end of the month
immediately preceding the date of publication of the research in the securities mentioned in this report.
The research professionals responsible for the preparation of this document may interact with trading desk personnel, sales personnel
and other parties for the purpose of gathering, applying and interpreting information. Subject Company may have been a client of MCL or
its associates during twelve months preceding the date of distribution of the research report. MCL or its associates may have investment
banking and other business relationships with some companies covered by our Research Department. Any or all of the foregoing among
other things, may give rise to real or potential conflicts of interest.
MCL and it's associates may have managed or co-managed public offering of securities, may have received compensation for investment
banking or merchant banking or brokerage services, may have received any compensation for products or services other than investment
banking or merchant banking or brokerage services from the subject company in the past 12 months. MCL and it's associates have not
received any compensation or other benefits from the subject company or third party in connection with the research report.
Microsec Capital Ltd. (“MCL”) is SEBI registered Research Analyst under SEBI (Research Analyst) Regulation 2014 having registration
Number INH300002407. Besides, MCL is SEBI registered stock broker, Depository Participant, Merchant Banker, Portfolio Management
Services, AMFI registered Mutual Fund distributor, Insurance Repository, POP with PFRDA.
The Company issues research reports to clients/prospective clients/others without any additional fees/charge.No material disciplinary
action impacting equity research analysis activities has been taken by any statutory/ Regulatory authority against MCL.
Analyst Certification The matter related to the report has been taken from sources believed reliable and the views expressed about the
subject or issues in this report accurately reflect the personal views of the analyst/analysts. MCL does not compensate partly or in full,
directly or indirectly, related to specific recommendations or views expressed by the research analysts. Disclosure of interest statement of
research analyst is as below:
1.Analyst’s ownership of the stocks mentioned NIL
2.Served as an officer, director or employee in subject Company NO
Office No: 6 , 5th floor Tower- IInd,
Stellar IT Park Plot No. C -25 , Sector – 62 ,
Noida – 201309 . Delhi NCR Phone : +91-120-4155509
Email: [email protected], Website: www.microsec.in
